Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (1)
STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX)...
Source: europapress.es
Jonathanm Barratt News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jonathanm Barratt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jonathanm Barratt Today - Breaking & Trending Today
Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet
/PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced publication in The Lancet of the full data...
Source: prnewswire.com
Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (2)
STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX)...
Source: europapress.es